Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the District Health Plan topic
No spam. Unsubscribe anytime.
Edinburg CISD board directed staff to pursue international pharmacy option to curb rising health-plan costs
Summary
After a detailed presentation of rising medical and pharmacy claims, district insurance staff recommended an international pharmacy program to reduce specialty drug spending; the board directed staff to draft procurement documents and return to a workshop for vendor review.
Edinburg Consolidated Independent School District trustees heard a briefing Tuesday on sharply rising medical and pharmacy claims and voted to give staff direction to pursue an international pharmacy program and related procurement work.
Dustin Garza, the district’s insurance manager, told the board the district’s total paid claims have climbed steadily since 2018 and that the plan has been strained by a recent cluster of very high-cost claimants that drove stop-loss reimbursements higher in 2022–23. “When we're not bringing in enough premium dollars to cover the expenditures, that's where we've seen the fund balance shrink over time,” Garza said.
Garza and staff presented figures the district tracks in its packet: paid claims in recent years in the tens of millions of dollars, and a health fund that finished the fiscal year with about $35,000 on hand after a one-time transfer and a $100 per-employee premium increase. Garza warned the board that, absent targeted action, the plan will eventually require either higher premiums or cuts to plan design and access.
To avoid those options, Garza recommended pursuing an international pharmacy program that would import bioequivalent brand-name medications from tier‑1 countries (for example, Canada, the U.K., Australia and New Zealand) to reduce specialty-drug spending. He said the program is voluntary at first, could be implemented mid-plan year if the board approves moving forward, and would include an RFQ/RFP to select vendors, a 30–45 day procurement window and roughly 60 days of employee education prior to enrollment. “You can implement this mid plan year. We don't have to wait till the end of the plan year,” Garza said.
Board members asked about precedent and timeline. Garza said several large self-insured employers have adopted international pharmacy solutions; some later made participation mandatory after seeing savings. He advised preparing an RFQ within 30–45 days if the board approves and bringing vendor presentations to a board workshop.
Trustees did not set a formal deadline but approved a motion to give the superintendent and staff direction to proceed with procurement planning and return with vendor evaluations and education plans. The discussion also flagged federal tariff activity as a potential uncertainty Garza said would not stop the district from doing due diligence.
The presentation tied the international pharmacy recommendation to broader cost-containment steps the district may consider in the future, including new coverage tiers, plan-design changes and dependent‑spouse surcharges, but Garza emphasized the international pharmacy option as the least disruptive immediate step.
The board’s direction does not change current plan design; it authorizes staff to develop vendor solicitations and educational materials for later board action.
